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Proline cis-trans isomerization and its implications for the 
dimerization of analogues of cyclopeptide stylostatin 1: a 
combined computational and experimental study  
C. López-Martínez,§a P. Flores-Morales,§b M. Cruz,a T. González,c M. Feliz,c A. Diez,a and Josep M. 
Campanera*d 
Cis and trans proline conformers are often associated with dramatic changes in the biological function of peptides. A slow 
equilibrium between cis and trans Ile-Pro amide bond conformers occurs in constrained derivatives of the native marine 
cyclic heptapeptide stylostatin 1 (cyclo-(NSLAIPF)); a potential anticancer agent. In this work, four cyclopeptides, cyclo-
(NSTAIPF), cyclo-(KSTAIPF), cyclo-(RSTAIPF) and cyclo-(DSTAIPF), which are structurally related to stylostatin 1, are 
experimentally and computationally examined in order to assess the effect of residue mutations on the cis–trans 
conformational ratio and the apparent capacity to form dimeric aggregates. Primarily, cyclo-(KSTAIPF) and cyclo-(RSTAIPF) 
showed specific trends in circular dichroism, MALDI-TOF and HPLC purification experiments which suggests the occurrence 
of peptide dimerization. Meanwhile, NMR spectrum of cyclo-(KSTAIPF) indicates that this cyclopeptide exists in the two 
slow-exchange families of conformations mentioned above. Molecular dynamics simulations combined with quantum 
mechanical calculations have shed light on the factors governing the cis/trans conformational ratio. In particular, we have 
found that residue mutations affect the internal hydrogen bond pattern which ultimately tunes the cis/trans 
conformational ratio and that only trans conformers are capable of aggregating due to the shape complementarity of the 
two subunits. 
1. Introduction 
Naturally occurring cyclopeptides represent a rich source of 
bioactive compounds with unusual and potent biological 
activities. The size and chemical complexity of cyclic peptides 
makes them suitable scaffolds to target shallow and extended 
binding interfaces, including targets with a low-druggability 
such as protein–protein interactions.1,2 These compounds fall 
outside the “drug-likeness” concept generally applied to small 
organic molecules; but they do define a chemical space that 
may provide useful scaffolds in drug discovery.3,4 Compared to 
linear peptides, cyclic peptides have enhanced therapeutic 
potential, as they have improved metabolic stability, cell 
permeability and oral bioavailability.5,6 Furthermore, 
cyclization should increase binding affinity by eliminating 
unproductive conformations that are accessible for linear 
peptides. 
 Conformational flexibility is a key factor when it comes to 
understanding the biological role of cyclopeptides.7 The choice 
of cyclization strategy, the presence of non-proteinogenic 
units, the polarity of the solvent and the physicochemical 
properties conferred by residues may be exploited to control 
the conformational behaviour,8,9,10 which in the case of 
cyclopeptides containing Pro can be drastically affected by the 
cis-trans isomerization.11 In proteins, approximately 6% of X-
Pro peptide bonds are found in the cis conformation, mostly 
lying close to the surface.12,13 Pro-Pro, aromatic-Pro and Pro-
aromatic sequences have the highest propensities to form a 
cis-prolyl amide bond.14 Due to their tendency to induce turns, 
the impact of Pro residues on the constrained conformation of 
cyclic peptides, and hence on their biological activity, is crucial. 
 For instance, while the two Pro residues in euryjanicin D 
(cyclo-(SIPLFPI) abbreviated to c(SIPLFPI) hereafter) are found 
in the cis conformation,15 the two Pro residues in its structural 
isomer stylopeptide 1 (c(PLIFSPI)) are found in trans and cis 
conformations.16 Furthermore, the cyclic heptapeptide 
ceratospongamide, which contains two Pro residues, is found 
in both the cis,cis and trans,trans conformations, but only the 
latter leads to potent inhibition of phospholipase A2.17 
Moreover, residue mutations can affect the cis/trans 
conformational ratio, as exemplified by the fact that 
replacement of the serine residue in the cyclic peptide 
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sequences c(-dXaa-Ser-Pro-dXaa-Lys-Pro-), by either 
phosphoserine or tyrosine, increases the cis conformation 
content of both prolines.18 Likewise, the residue sequence has 
also been reported to have a decisive influence on the 
cis/trans ratio in contryphans, a 23-membered cyclic disulfide 
moiety.19 
 In previous studies,20 we used the cyclic heptapeptide 
stylostatin 1 (c(NSLAIPF))21 as a template for the synthesis of 
pseudostylostatins to be studied as potential anticancer 
agents. In those compounds, the Ser-Leu pair was replaced by 
a lactam (piperidone) dipeptide to modulate the molecular 
conformation.22 Both NMR and X-ray analysis showed that 
stylostatin 1 is found in a cis Ile-Pro conformation, which is 
stabilized by three internal hydrogen bonds.20,21 However, 
inclusion of the lactam dipeptide yielded pseudostylostatins 
that adopted both cis and trans conformations. Although the 
turn centred on the Ser-Leu dipeptide was successfully 
mimicked by the piperidone surrogate, it induced the 
destabilization of the internal hydrogen bonds found in 
stylostatin 1, and the increased flexibility allowed for the onset 
of the Ile-Pro trans conformation. In contrast, replacement of 
Ile by D-allo-Ile only rendered the trans conformation; this 
probably reflects the steric effect around the α-carbon of D-
allo-Ile on the D-allo-Ile-Pro bond. Overall, these findings 
revealed the high structural sensitivity of stylostatin 1 to 
seemingly minor structural alterations. 
 Here, we now present combined experimental and 
theoretical work23 on the factors governing the cis-trans 
isomerization of the stylostatin c(NSLAIPF) and four other 
pseudostylostatins, namely c(NSTAIPF), c(KSTAIPF), c(RSTAIPF) 
and c(DSTAIPF). Our principal aim is to establish the structural 
causes that determine the cis/trans Ile-Pro peptide bond 
conformational ratio and the preferences of these conformers 
to form aggregates. We are specifically interested in 
determining how the mutated residues affect the internal 
hydrogen bonding pattern, which we hypothesize constitutes 
the main determinant of the cis-trans isomerization.20 Of the 
five pseudostylostatins, c(KSTAIPF) showed a remarkable 
capacity to form dimeric aggregates and thus was taken as the 
reference compound for an in-depth study. 
 The present study uses circular dichroism (CD), MALDI-TOF, 
HPLC and NMR techniques to experimentally characterize the 
conformational preferences, and extensive molecular 
dynamics (MD) simulations (around 6 μs in explicit waters) to 
elucidate the structure of cis and trans confomers of the 
monomer cyclopeptides as well as the structure of the dimer 
aggregates. Finally, DFT/M06-2X calculations are performed 
for representative members of the MD conformational 
ensembles to assess the relative stability of the cis and trans 
conformers, and to offer insight into the structural and 
physicochemical determinants that underlie the cis/trans 
conformational ratio and the capacity to form dimeric 
aggregates.  
2. Results and Discussion 
2.1. Design and synthesis of the pseudostylostatins 
A set of four new cyclic peptides was designed to potentially 
modify the cis/trans isomerization ratio of the native 
stylostatin 1 (c(N1S2L3A4I5P6F7) with the numbering of the 
amino acid residues), which is also included in the present 
study (Figure 1). The pseudostylostatins were generated by 
replacing the residues at positions 1 (the position at which one 
of the internal hydrogen bonds is formed) and 3 by residues 
that incorporate additional capacity to form hydrogen bonds. 
So, the mutation of the apolar residue Leu3 in c(NSLAIPF) by 
Thr, giving rise to c(NSTAIPF). The remaining three compounds 
are designed by replacing the neutral residue Asn1 by the 
charged residues Lys (c(KSTAIPF)), Arg (c(RSTAIPF)) and Asp 
(c(DSTAIPF)). Apart from exploring the different possibilities 
for altering the intramolecular hydrogen pattern, these 
mutations were also motivated by the search for cationic 
antimicrobial peptides (AMPs), which exhibit cytotoxic activity 
against cancer cells.24 Such AMPs require the presence of a 
positively charged residue (the mutation at position 1 of Asn to 
Lys and Arg in contrast to Asp) and also a certain amphiphilic 
character (mutation at position 3 from the hydrophobic 
residue Leu to the polar residue Thr). 
 The peptides were synthesized by closure of the Pro6-Phe7 
bond (Figure S1; see also Experimental Section). We used 2-
chlorotrityl (ClTrt) resin, which facilitated the anchoring of Pro 
as the first amino acid, avoided diketopiperazine formation 
and enabled cleavage in mild conditions, thus allowing the side 
chains to remain protected for subsequent cyclization in 
solution. Since ClTrt resin is sensitive to acid media, for each 
step we first verified the completion of the coupling (Kaiser 
test), and then deprotected the amino group with 20% 
piperidine in dimethylformamide. This procedure was found to 
improve the synthetic yield compared to our previous work.20 
Commercial ClTrt resin with Pro already anchored as the first 
amino acid (H-Pro-2-ClTrt, Novabiochem, 0.3-0.9 mmol/g of 
resin, ref. 04-12-2805) gave the best results. Natural amino 
acids were coupled using Fmoc-aa-OH/HOBt/DIPCDI (3:3:3). In 
order to remove the protective groups from the side chains, a 
final deprotection step was performed using TFA/H20 (95:5). 
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All the compounds were purified by reverse-phase HPLC. 
Cyclopeptides were thus obtained in chemical yields of 12%-
20% and with HPLC purities of 96%-98%. Finally, because the 
peptides were highly hygroscopic and difficult to manipulate, 
they were characterized by standard HPLC, amino acid analysis 
and MALDI-TOF mass spectrometry. 
 
2.2 Electronic circular dichroism (CD) and MALDI-TOF analysis 
Electronic CD spectra were recorded in water solutions at 
various concentrations for all the compounds. The CD spectra 
of c(NSLAIPF), c(KSTAIPF) and c(DSTAIPF) (Figure 2), chosen as 
illustrative examples, show features similar to those found in 
the CD spectra of other cyclopeptides, such as c(GPSG-(δ)Ava) 
and c(FpGRGD), where (δ)Ava and p mean 5-amino valeric acid 
and D-Pro, respectively.25,26 The spectra show negative bands 
at around 215-220 and 200-205 nm, which correspond to the 
n→π* and π→π* excitons, respecRvely; and a posiRve band 
below 200 nm. These features, which resemble those found in 
α-helix CD spectra but have smaller amplitudes, suggest the 
presence of a type I β-turn (class C spectra following Woody's 
nomenclature).27 This probably reflects the turn geometry of 
the X1SXA4 segment and its analogous NSLA segment in 
c(NSLAIPF), which possesses such a conformational motif in its 
structure, as determined by X-ray and NMR analysis.20,21  
 The CD spectra showed three types of patterns when the 
cyclopeptide concentration was varied in the range 3-60 μM 
(see Figure 2 for illustrative examples and Figure S2 for the 
remaining cyclic peptides). On the one hand, the c(DSTAIPF) 
spectrum did not show any relevant changes as the 
cyclopeptide concentration increased (Figure 2b); while the 
c(RSTAIPF) and especially c(KSTAIPF) spectra were significantly 
altered as the concentration was increased to 60 μM, leading 
to a flattening of the spectra in the 200-230 nm region (Figure 
2a). On the other hand, c(NSLAIPF) and c(NSTAIPF) presented 
intermediate behaviour between the two abovementioned 
patterns (Figure 2c), with a slight alteration of the CD spectra 
due to the increase of the concentration. This finding in 
c(RSTAIPF) and c(KSTAIPF) suggested that the increase in 
concentration promotes a structural alteration that could stem 
from either self-aggregation28 or the conversion of one 
conformation of the cyclopeptide to another.29 
 The former interpretation is supported by the analysis of 
MALDI-TOF spectra, which showed that all the compounds 
exhibit the expected molecular peaks [M+H]+, [M+Na]+ or 
[M+K]+, but that c(KSTAIPF), c(RSTAIPF) and c(NSLAIPF) also 
showed a [2M+H]+ peak, thus indicating the existence of 
dimeric species for these cyclopeptides (see Figure 3 for 
c(KSTAIPF) and Figure S3 for the remaining cyclopeptides). The 
ambiguous results for c(NSLAIPF) might be related to the 
different sensitivity of the CD and MALDI-TOFF techniques. It 
could also be related to the slightly different experimental 
conditions used in the two techniques, which could displace 
the subtle equilibrium between the monomeric and the 
dimeric forms in a peptide that clearly shows intermediate 
   
(a) CD pattern with clear alteration as the concentration 
increases 
(b) CD pattern with any significant alteration (c) CD pattern with intermediate behaviour 
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behaviour between those that aggregate and those that do 
not. In line with the previous findings, HPLC purification of 
c(KSTAIPF) revealed the presence of two major peaks and 
several smaller peaks that lie close together at room 
temperature, and also the coalescence of these peaks upon 
heating to 45ºC (Figure S4). On the basis of the previous 
findings, it can be speculated that the peaks reflect an 
equilibrium between distinct conformational states and even 
aggregated species, which would appear as a single peak in the 
chromatogram when the temperature is raised. Finally it is 
important to highlight that the atypical behaviour, especially of 
c(KSTAIPF) and c(RSTAIPF), cannot be attributed merely to 
overall physicochemical properties; rather we hypothesize that 
it could reflect the alteration of the internal hydrogen pattern 
caused by each specific residue mutation. 
  
2.3. NMR study of c(KSTAIPF) 
 To gain further insight into the above findings, we 
undertook 1H and 13C NMR analysis of c(KSTAIPF) in DMSO. 
Unfortunately the NMR analysis could not be performed in 
water as the other experiments were since the limited 
solubility of the cyclopeptides in water impeded to achieve the 
concentration required for NMR analysis.30 The spectra 
showed two main sets of signals, which were identified as the 
cis and trans Ile-Pro conformations based on the characteristic 
13C chemical shift difference between β- and γ-carbon atoms 
(Δδβ,γ) of cis X-Pro (Δδβ,γ ≥ 8 ppm) and trans X-Pro (Δδβ,γ < 6 
ppm) dipeptides, a method pioneered by Siemion et al.31,32,33 
The higher set of signals showed a Δδβ,γ of 4.6 ppm, indicating 
that the major conformation contains a trans Ile-Pro; while the 
secondary set of signals (Δδβ,γ = 9.7 ppm) corresponds to the 
cis Ile-Pro conformation. Notably, Diez et al.  measured a value 
of 9 ppm for Δδβ,γ of c(NSLAIPF),
20 which indicated a cis 
conformation of the Ile-Pro amide bond, in agreement with 
the reported X-ray structure.21 In this previous work, they also 
reported that an increase of the proportion of DMSO 
decreases the cis/trans conformational ratio in constrained 
derivatives of c(NSLAIPF), as a solvent-induced isomerization 
effect,34 which is in line with the present findings that the trans 
conformer dominates over the cis conformer in pure DMSO; 
though in water, the cis conformer might be the more 
populated one, as in the case of c(NSLAIPF).   
 The structural analysis of the trans conformer showed NOE 
correlations35 not only between vicinal residues, but also 
between NH protons of the pairs Ser-Ile, Thr-Ile and Ala-Ser 
(green circles in Figure 4 and Table S1). This indicates that the 
cyclopeptide may adopt a conformation that contains a β-turn 
involving the Ser2i-Thr
3
i+1-Ala
4
i+2-Ile
5
i+3 fragment and 
consequently an intramolecular bond between the CO of Ser2 
and the HN of Ile5. For the cis Ile-Pro conformer, NOE 
correlations between NH protons of the pairs Phe-Ala, Ala-Lys 
and Ser-Ile were found (purple circles in Figure 4 and Table S1). 
This could be explained by two extra hydrogen bonds between 
the NH groups of Ala and Phe and the carbonyl units of Lys and 
Ala, respectively, which would stabilize the backbone 
conformation by forming two β-turns. The IR spectrum of 
c(KSTAIPF) resembles to that of an antiparallel β-sheet, which 
Table 1. Phi and psi backbone torsional angles (degrees) and distances (Å) of β- 
and γ-turns in cis and trans c(KSTAIPF).a 
φi+1 ψi+1 φi+2 ψi+2 d1
b d2
 c
 
cis 
Type I β-turn: K1i-S
2
i+1-T
3
i+2-A
4
i+3 
-62±11 
(-60) 
-27±13 
(-30) 
-101±19 
(-90) 
-18±19 
(0) 
5.0±0.2 
(<7) 
3.2±0.3 
Type VIa1 β-turn: A4i-I
5
i+1-P
6
i+2-F
7
i+3 
-69±12 
(-60) 
146±8 
(120) 
-86±8 
(-90) 
-10±15 
(0) 
6.2±0.4 
(<7) 
3.2±0.3 
trans 
Type II β-turn: S2i-T
3
i+1-A
4
i+2-I
5
i+3 
-63±13 
(-60) 
138±17 
(120) 
59±8 
(80) 
6±20 
(0) 
5.9±0.3 
(<7) 
3.7±0.4 
 
Standard γ-turn: F7i-K
1
i+1-S
2
i+2 
56±10 
(80) 
-9±34 
(-65) 
- - 
5.8±0.2 
(<7) 
2.9±0.2 
Inverse γ-turn: I5i-P
6
i+1-F
7
i+2 
-67±11 
(-80) 
-9±20 
(65) 
- - 
5.7±0.2 
(<7) 
3.1±0.2 
a Ideal values are reported in parenthesis (ref. 35).  
b Distance between Cα carbons of residues i and i+2 (γ-turn) or i+3 (β-turn).  
c
 Distance from carbonyl oxygen of residue i and the nitrogen of the NH 
peptide unit of residue i+2 (γ-turn) and i+3 (β-turn). See Table S2 for the 
values of other cyclopeptides. 
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is characterised by two concomitant transitions: a strong 
transition between 1610 and 1640 cm-1 (peak at 1620 cm-1 in 
our case) and a weak transition at higher wavenumbers 
(shoulder at 1640 cm-1), see Figure S5. It therefore supports 
our finding of intramolecular hydrogen bonds.36,37,38,39 
Interestingly, some correlations between the sets of signals for 
trans and cis species were observed for Ile, Thr, Phe and Ser 
(dotted circles in Figure 4). These signals also appeared in the 
ROESY experiment (Figure S6), but with an inverted sign; thus 
confirming the slow exchange between conformations. Note 
that there are no findings regarding the presence of a dimer 
aggregate in the present NMR study, which has to be related 
to the effect of the DMSO solvent.  
 
2.4. Molecular dynamics of monomeric cis and trans conformers 
of c(KSTAIPF) and the other cyclopeptides 
A series of restrained MD simulations were used to obtain 
structural models of cis and trans conformers of c(KSTAIPF). 
The X-ray structure of c(NSLAIPF), where the Ile-Pro peptide 
bond adopts a cis conformation, was used as a template to 
build the cis c(KSTAIPF). Meanwhile, the trans conformation 
was built from its cis counterpart by modifying the Ile-Pro 
bond and applying the geometrical restraints derived from the 
NOE correlations of the NMR study between non-vicinal 
residues. All the other conformers of the cyclopeptides were 
built from the initial models of cis c(NSLAIPF) and trans 
c(KSTAIPF) (see Experimental Section and Figure S7). 
 First of all, it is important to mention that simulated cis 
c(NSLAIPF) reproduces all the structural features of the 
reported X-ray structure21 and secondly, that MD simulations 
yield stable structures of both cis and trans conformers for all 
the cyclopeptides. The cis c(KSTAIPF) presents a type I β-turn 
involving the residues Lys1-Ser2-Thr3-Ala4 and a type VIa β-turn 
with the residues Ala4-Ile5-Pro6-Phe7 (Table 1 and Figure 5).40 
Moreover, the Ile carbonyl group was oriented towards the 
exterior of the molecule, in agreement with the cis Ile-Pro 
conformation. These turns are accompanied by the 
corresponding hydrogen bonds: one between Ala(NH) and 
Lys(CO) in the type I β-turn, and the other between Phe(NH) 
and Ala(CO) in the type VIa β-turn. Additionally, the NH 
peptide group of Lys1 points towards the interior of the 
cyclopeptide and interacts weakly with the CO of Ala4. In 
summary, all these geometrical features of cis c(KSTAIPF) 
resemble those found in the backbone conformation of cis 
c(NSLAIPF), as reported in the work by Pettit et al.21 
 Meanwhile, the trans c(KSTAIPF) showed a single type II β-
turn involving the Ser2-Thr3-Ala4-Ile5 fragment and two γ-
turns41 (Phe7-Lys1-Ser2 and Ile5-Pro6-Phe7) with their 
corresponding distorted hydrogen bonds, see Table 1 and 
Figure 5 for distances and geometries. It is important to 
remark that γ-turn involving Phe7-Lys1-Ser2 fragment competes 
with the transient hydrogen bond between backbone of 
Phe(CO) and side chain of Ser(OH). Notice also that the 
orientation of the Ile carbonyl group towards the interior of 
the molecule is also in agreement with the trans Ile-Pro 
assignment for the major conformer in the NMR study.  
 The cis and trans conformers of the other mutated 
cyclopeptides keep the same structural features as c(KSTAIPF) 
with regard to the backbone interactions (see Table S2 for the 
average distances in β- and γ-turns, and Figure 6 for the 
conformational space explored by the backbone skeleton of 
each cyclopeptide). The differences appear in the formation 
and strength of extra internal hydrogen bonds that involve 
residue side chains. First, none of the trans conformers contain 
  
 
 cis c(KSTAIPF) trans c(KSTAIPF) 
P6 
F7 K1 S2 
T3 
A4 I5 
I5 
S2 
T3 
A4 
P6 
F7 
K1 
Page 5 of 13 Physical Chemistry Che ical Physics
P
hy
si
ca
lC
he
m
is
tr
y
C
he
m
ic
al
P
hy
si
cs
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
31
 M
ar
ch
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
t d
e B
ar
ce
lo
na
 o
n 
04
/0
4/
20
16
 1
2:
34
:2
3.
 
View Article Online
DOI: 10.1039/C5CP05937B
ARTICLE Journal Name 
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
any extra hydrogen bonds other than those involved in the β- 
and γ-turns described above. This trend reflects the inability of 
mutated residues of trans conformers to form hydrogen bonds 
involving side-chain residues due to their overall shape, which 
orients the side chain toward the solvent (see Figure 5). In 
contrast, cis conformers of c(NSLAIPF), c(NSTAIPF) and 
c(DSTAIPF) contain extra hydrogen bonds between the side-
chain residue at position 1 (Asn, Asn and Asp, respectively) and 
the backbone or side chain at position 3 (Leu, Thr and Thr, 
respectively). The characterization (bond lengths and intensity 
of the interactions) of the additional hydrogen bonds for cis 
c(NSLAIPF), c(NSTAIPF) and c(DSTAIPF) is listed in Table 2 and 
displayed in Figure 7. Cis c(NSLAIPF) contains two additional 
hydrogen bonds: one (Asn1-CO···HN-Leu3) was already 
identified by Petit et al. in their X-ray model;21 and the other is 
a weak and transient interaction (Asn1-CO···HN-Ala4). Cis 
c(NSTAIPF) also presents an additional weak hydrogen bond 
(Asn1-CO···HO-Thr3), while cis c(DSTAIPF) shows one additional 
strong hydrogen bond (Asp1-COO-···HN-Ser2) and two weak 
interactions. This differences in the internal hydrogen bond 
pattern between all the cyclopeptides could tune the cis/trans 
conformational ratio as already claimed for proline 
derivatives.42 
 
2.5. Estimation of the cis/trans conformational ratio of monomeric 
cyclopeptides by semiempirical and quantum mechanical 
calculations 
 To further confirm the stabilizing role of the additional 
hydrogen bonds found in cis conformers of c(NSLAIPF), 
c(NSTAIPF) and c(DSTAIPF) compared to cis conformers of 
c(KSTAIPF) and c(RSTAIPF) and their effect on the cis/trans 
conformational ratio, we performed extensive semiempirical,  
DFT and MP2 calculations. The direct aim of these calculations 
was to determine the relative stability of both conformers of 
each cyclopeptide. So, 256 conformations (on average, 26 
conformers per isomer of each cyclopeptide, see Table S3 and 
Figure S8) extracted from the aqueous MD simulations were 
subjected to geometry optimization and frequency calculation 
at the semiempirical/PM6-DH+/COSMO43,44 and DFT/M06-
2X/6-31G(d)/SMD45,46 levels, in order to derive the relative 
stabilities of each conformer (see Table 3 and Experimental 
Section for details). It is important to note that these methods 
explicitly incorporate non-covalent interactions into their 
parameterizations.47,48 
 Although caution is required when interpreting the 
absolute values in Table 3, the two methods agree in the 
relative order of the stability between the cis and trans 
Cyclopeptide Bond 
acceptor 
Bond donor Average 
distance 
(Å) along 
100 ns 
% 
time 
below 
3.5 Å 
c(NSLAIPF) Side chain 
Asn1 (CO) 
Main chain Leu3 
(NH) 
3.1 ± 0.5 92 
  Main chain Ala4 
(NH) 
3.5 ± 0.8 61 
c(NSTAIPF) Side chain 
Asn1 (CO) 
Side Chain Thr3 
(OH) 
3.7 ± 1.0 57 
c(KSTAIPF) - - - - 
c(RSTAIPF) - - - - 
c(DSTAIPF) Side chain 
Asp1 (COO-) 
Main chain Ser2 
(NH) 
3.4 ± 0.5 65 
  Main Chain Thr3 
(NH) 
3.9 ± 0.9 48 
  Side Chain Thr3 
(OH) 
4.7 ± 1.0 13 
Cyclopeptide PM6-
DH+b 
M06-2X/6-
31G(d)b 
M06-2X/6-
31G(d,p)c 
MP2/6-
31G(d)d 
c(NSLAIPF) -7.5 -7.6 -6.7 -4.1 
c(NSTAIPF) -8.2 -6.0 -4.9 -4.7 
c(KSTAIPF) -2.6 -4.8 -3.5 -3.0 
c(RSTAIPF) -3.6 -5.7 -5.5 -4.0 
c(DSTAIPF) -9.4 -13.5 -13.1 -8.4 
a See methodology section to find out how these values have been 
estimated. See also Table S5, S6, S7 and S8. A negative sign denotes a 
preference for the cis conformers. Additional results at M06-2X/def2-TZVP 
can be found in the Table S4.b Relative Gibbs free energy using 256 
conformations. c Relative energy from geometry optimization calculations 
on the 67 most important conformations from M06-2X/6-31G(d) level of 
theory. d Relative energy from single point calculations on the 67 most 
important conformations from M06-2X/6-31G(d) level of theory. 
cis c(NSLAIPF) 
cis c(DSTLAIPF) 
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conformers. The results show that the cis conformer is more 
stable than the trans species in all the cyclopeptides regardless 
of the residue mutation: they range from -2.6 to -9.4 kcal/mol 
with PM6-DH+, and from -4.8 to -13.5 kcal/mol with M06-
2X/6-31G(d). This agrees with the expectation that two β-turns 
(cis conformers) are more stabilizing than one β-turn and two 
γ-turns (trans conformers). So, the two methods give the 
following order for the relative stability of cis and trans 
conformers: c(DSTAIPF) < c(NSTAIPF) ≈ c(NSLAIPF) < c(RSTAIPF) 
< c(KSTAIPF). Additional calculations with fewer conformations 
but with larger basis sets (M06-2X/6-31G(d,p) and M06-
2X/def2tvzp) and with a wavefunction-based method such as 
MP2/6-31G(d) yield the same qualitative results, see Table 3 
and Table S4. The computed cis/trans ratio order correlates 
well with: a) the alteration of the CD spectra as the 
concentration of the cyclopeptide increases; b) the detection 
of double mass peaks in the MALDI-TOF spectra; and c) the 
number of additional hydrogen bonds that result from the 
mutated side-chain residues. Thus, within the uncertainty of 
the absolute estimates reported in Table 3, it is important to 
note that the smallest differences between the relative 
stabilities of cis and trans conformers are found for c(KSTAIPF) 
and c(RSTAIPF); which are the cyclopeptides that exhibit the 
most significant changes in their CD and MALDI-TOF spectra. In 
contrast, the differences found for the other three 
cyclopeptides appear to be large enough to rule out a 
conformational equilibrium between the cis and trans 
conformers, especially for c(DSTAIPF). To sum up, the present 
QM calculations support the view that there is a cis-trans 
conformational equilibrium highly displaced toward the cis 
conformations in water, but with an increasing presence of the 
trans conformations for c(RSTAIPF) and c(KSTAIPF) . 
 
2.6. Dimerization of c(KSTAIPF) and the other cyclopeptides 
The concentration-dependent change observed in the CD 
spectra (Figure 2) and the identification of species with a mass 
corresponding to the dimer in the MALDI-TOF assay (Figure 3) 
suggest the capacity of c(KSTAIPF) and c(RSTAIPF) to dimerize. 
Keeping in mind the presence of both cis and trans conformers 
in the NMR study and the similar stability of both species from 
the previous section, this raises a challenging question 
regarding the nature of the monomeric species involved in 
peptide aggregation. From a geometrical point of view, the 
cyclopeptide ring in trans c(KSTAIPF) adopts a planar-like 
structure, which is in contrast with the folded ring found in the 
cis conformer (see Figure 5). Therefore, whereas in the cis 
conformation the side chains are pointing toward the two 
faces of the ring, the side chains in trans c(KSTAIPF) are 
oriented toward one face of the ring, leaving the other largely 
exposed to the bulk solvent. Finally, it is worth noting that 
trans c(KSTAIPF) exposes a highly homogeneous hydrophobic 
surface to the solvent; a feature that it has been proposed as 
an essential requirement for promoting aggregation.41 
 The formation of the dimeric species was examined by 
means of MD simulations. To this end, up to five distinct 
orientations of dimeric c(KSTAIPF) were generated by changing 
the relative orientation of the stacked cyclopeptides in order 
to find the most favourable arrangement (Figure S9). All the 
attempts made to find stable structures for the cis,cis and 
cis,trans dimeric species were unsuccessful: the MD 
trajectories led to the dissociation of the aggregate. In 
contrast, the trans,trans conformation led to a stable structure 
in seven out of eight independent 100 ns MD replicas run for 
this dimer. Gratifyingly, MM-GBSA, MM-PBSA and MM-RISM 
calculations confirmed that the binding free energy of the 
trans,trans dimer (-23.2, -12.1, -3.9 kcal/mol, respectively) is 
Table 4. Binding free energies of the trans,trans dimer cyclopeptides estimated 
by MM-GBSA, MM-PBSA and MM-RISM methodologies from 100 ns of 
unconstrained MD simulations, in kcal/mol.a 
Cyclopeptides MM-GBSA MM-PBSA MM-RISM 
c(NSLAIPF) -24.4 -12.0 -4.3 
c(NSTAIPF) -23.2 -12.7 -4.1 
c(KSTAIPF) -23.2 -12.1 -3.9 
c(RSTAIPF) -22.0 -10.7 -3.3 
c(DSTAIPF) -23.9 -12.2 -4.8 
a See methodology section to find out how these values have been 
estimated. 
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more favourable than for the cis,cis dimer (-13.0, -5.3, -1.3 
kcal/mol; in this case, the calculations were performed for the 
subset of snapshots taken before dissociation of the dimer). 
 The interaction between trans monomers depends upon 
the way in which the planar faces of the two monomers align 
(see Figure 8). Whereas the solvent-accessible surface of the 
monomer amounts to around 900 Å2, formation of the dimer 
reduces the surface exposed to solvent by around 20% (a total 
solvent-accessible area of some 1400 Å2). This reduction is 
particularly important for Ala (60%), Thr (30%) and Pro (28%) 
residues. Three major features characterize the interaction 
between the monomers. First, the Lys residues in each 
monomer are well exposed to the solvent, and their side 
chains are oriented in opposite directions, thus reducing the 
electrostatic repulsion between the protonated amino groups. 
Second, the two Pro residues are aligned face to face. Third, 
two intermolecular hydrogen bonds that involve the backbone 
groups of the Ala and Ser residues of the interacting 
monomers are formed in the dimer (average distance of 3.0 
Å).  
 We would expect dimeric species to occur in the other 
cyclopeptides in a similar way to how it occurs in c(KSTAIPF) 
due to the structural resemblance of the cis and trans 
backbone skeleton in all monomeric cyclopeptides (see Figure 
6). Indeed, the simple mutation of the corresponding final 
trans,trans c(KSTAIPF) dimer gives rise to stable 200 ns MD 
simulations with a united dimeric form for all the 
cyclopeptides, see Table S9. Likewise, the binding free energy 
estimated using the MM-GBSA, MM-PBSA and MM-RISM 
methods yielded similar relative results for all the 
cyclopeptides; although there were great differences in 
absolute values between methods (Table 5). The higher-level 
MM-RISM computes binding free energies ranging from -4.8 to 
-3.3 kcal/mol. Such a small difference between dimers is 
expected since the mutated residues are not directly involved 
in the three main features that determine the binding 
between interacting monomers.  
 On the other hand, dimerization does not introduce 
significant changes in the β-turn secondary structure of the 
separate monomers. The only noteworthy alteration concerns 
one of the γ-turns (F7i-K
1
i+1-S
2
i+2); not only in terms of average 
values but also of the reduction of the standard deviation, 
which may indicate the structure becomes more rigid upon 
dimerization (compare Tables S10 and 1). This is also reflected 
in the principal component analysis projection of the backbone 
space measured by the Cartesian coordinates of the dimers 
over the corresponding backbone space of trans monomer 
c(KSTAIPF) displayed in Figure 9. Thus, monomers occupy a 
slightly larger conformational space than the assembled 
species in the dimer; which only implies a certain reduction in 
conformational flexibility upon dimerization.  
 
3. Conclusions 
 We have designed, synthesized and modelled a set of four 
cyclic heptapeptides based on mutations of the structure of 
c(NSLAIPF), a potential antibiotic agent, taking into account 
the need for residues with different capacities to form 
hydrogen bonds. The final aim was to alter the cis-trans Ile-Pro 
amide bond equilibrium and thereby rationalize the structural 
determinants of the cis-trans displacement in such derivatives 
of c(NSLAIPF). Of the synthesized set, two compounds, 
c(KSTAIPF) and c(RSTAIPF), showed clearly different behaviour 
that could be interpreted in terms of aggregation: i) a 
concentration-dependent change in the CD spectra; ii) a 
[2M+H]+ peak in the MALDI-TOF spectra; and iii) a double HPLC 
peak at room temperature that coalesces upon heating to 
45ºC (in the case of c(KSTAIPF)). Meanwhile, c(NSLAIPF) and 
c(NSTAIPF) presented intermediate behaviour; whereas 
c(DSTAIPF) showed no evidence of aggregation whatsoever. 
Although NMR could not be used to confirm the presence of 
the dimeric form of c(KSTAIPF) in water, NMR studies of 
c(KSTAIPF) in DMSO revealed the presence of two major 
conformations, cis and trans Ile-Pro conformations, which are 
primarily characterized by the presence of two β-turns in the 
former, and one β-turn and two γ-turns in the latter.  
 MD simulations in explicit water corroborated the 
feasibility of the monomeric cis and trans structures, as well as 
the capacity to form a sufficiently stable dimer only in the case 
of the trans species. Moreover, semiempirical/PM6-
DH+/COSMO, DFT/M06-2X/SMD and MP2/SMD calculations 
involving conformational ensembles of all cyclopeptides 
corroborate the preference to adopt the cis conformation, 
although only a small difference with the trans species is found 
for c(KSTAIPF) and c(RSTAIPF). The overall greater stability of 
the cis conformers than that of the trans conformers has to be 
attributed to the higher stability of two β-turns (cis 
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conformers) than that of one β-turn and two γ-turns (trans 
conformers). Meanwhile, the relative stability of cis 
conformers of c(DSTAIPF), c(NSTAIPF) and c(NSLAIPF) has to be 
assigned to the fact that, unlike cis conformers of c(KSTAIPF) 
and c(RSTAIPF), these cis conformers contain additional 
hydrogen bonds between side chains at position 1 and position 
3 that confer extra stability to the cis conformers compared to 
the trans conformers. From a qualitative point of view, these 
findings are in agreement with the findings that: i) no 
experiments indicate that c(DSTAIPF) forms a dimer structure; 
ii) both CD and MALDI-TOF experiments suggest that dimers of 
c(KSTAIPF) and c(RSTAIPF) form; and, finally, iii) c(NSLAIPF) and 
c(NSLAIPF) show intermediate behaviour between the 
preceding cases, since the CD spectra of both cyclopeptides 
display only a certain degree of concentration-dependent 
alteration, and only a tiny peak corresponding to the dimer 
was found for c(NSLAIPF). To sum up, as only trans conformers 
have the capacity to form aggregates, the displacement of the 
cis-trans equilibrium by either destabilizing the cis conformers 
or stabilizing the trans conformers will ultimately determine 
the formation and appearance of trans,trans dimer 
aggregates. 
 Putting all the pieces together, these findings allow us to 
suggest that this family of stylostatin derivatives exhibits a 
conformational equilibrium between trans and cis monomeric 
conformers, which: i) can be modulated by the capacity of 
residues to form internal hydrogen bonds; and ii) can be 
altered by the concentration-dependent formation of the 
trans,trans dimer. Thus, even though the dimerization does 
not lead to drastic structural changes in the monomers, the 
changes in the CD spectra probably reflect the displacement of 
the conformational equilibrium between cis and trans 
monomeric conformers due to the dominance of the cis 
conformer in the monomeric state and to the exclusive 
formation of the trans,trans dimer state. Overall, the results 
indicate that the capacity to dimerize should not be 
interpreted merely in terms of specific physicochemical 
properties of the cyclopeptide, but as indicating the presence 
of a suitable structural motif that permits interaction between 
the monomers. These findings could provide a useful guide for 
exploration of the displacement of the X-Pro cis-trans 
equilibrium in other cyclopeptide families. 
4. Experimental Section 
4.1. Peptide synthesis 
Solid-phase syntheses were carried out at 25°C in 
polypropylene syringes (5/10 mL) fitted with a polyethylene 
porous disk. Solvents and soluble reagents were removed by 
suction. Washing was performed with DMF (5 x 1 min) and 
DCM (5 x 1 min) using 10 mL of solvent per gram of resin for 
each wash. Fmoc-protected amino acids were used. The 
commercial (Novabiochem) side chain-protected amino acids 
used were: Fmoc-Ser(tBu), Fmoc-Thr(tBu), Fmoc-Asp(Trt), 
Fmoc-Lys(Boc), and Fmoc-Arg(Boc)2. 
 Commercial resin H-Pro-2-ClTrt (Novabiochem, 0.3-0.9 
mmol/g of resin, ref. 04-12-2805) was swollen with DMF and 
treated with the appropriate Fmoc protected amino acid, HOBt 
and DIPCDI in a 3:3:3 ratio. The mixture was manually stirred 
and left for 1 h, then the solvent was filtered off and the resin 
was washed with DMF. Piperidine (20% in DMF) was then 
added to the resin, and the mixture was left for 0.5 h, after 
which the liquid was filtered off and the resin was washed with 
DMF and with DCM. The same method was applied to the 
other five amino acids. Then the protected linear peptides 
were cleaved from the solid support by treatment of the resin 
with AcOH/TFE/DCM (2:2:6) for 2 h, and the solution 
containing the peptides was recovered. Cyclization through 
Pro6-Phe7 was performed by addition of PyBOP/DIEA (1.5:3) in 
DMF/DCM (97:3) to the linear peptide. The cyclization was 
monitored by analytical reversed-phase HPLC. Final 
deprotection of the side chains was performed with TFA/H2O 
(95:5). The peptides were then purified by HPLC and 
lyophilized. 
 
4.2. Purification and separation of cyclopeptides 
The compounds were purified using a Waters HPLC system 
with a SymmetryPrep C18 reverse phase preparative column 
(7.8 x 300 mm) with 7 m packing material. The crude peptides 
(50-100 mg) were dissolved in water/acetonitrile 1:2 (1 mL), 
filtered and injected through a Rheodyne injector with a 1 mL 
sample loop. The mobile phases used were A: 0.05% aqueous 
TFA and B: 0.05% TFA in acetonitrile, with a linear gradient 
from 10%B to 45%B over 40 min (3 mL/min). The fractions 
were manually collected at 1 min intervals. Elution of the 
peptide was determined simultaneously from the absorbance 
at 220 and 254 nm (Waters 2487). The fractions were re-
injected to assess purity via analytical reversed-phase HPLC 
(Waters NovaPak C18, 3.9 x 150 mm, 4m). In this case, we 
used a linear gradient from 0% B to 100% B over 30 min for 
peptide characterizations. Retention times observed at 220 nm 
under two different conditions are given. The pure fractions 
were combined and lyophilized. Each peptide showed [M+H]+, 
[M+Na]+ and/or [M+K]+ peaks in its mass spectrum, and each 
was >90% pure. The samples were lyophilized to yield highly 
hygroscopic white solids. The structure of all the compounds 
was confirmed by amino acid analysis and MALDI-TOF (using 
ACH as the matrix). In addition, NMR experiments were 
performed on c(KSTAIPF). The NMR signal assignments 
required 2D-TOCSY, COSY (H,H), 2D-HSQC, 2D-NOESY, and 2D-
ROESY experiments.  
 
4.3. Spectroscopic analysis 
 The cyclopeptides were characterized by MALDI-TOF mass 
spectrometry (Voyager-DE RP MALDI-TOF, PE Biosystems with 
an N2 laser at 337 nm). 1 μL of the compound solution (0.5-2 
mg/mL) was mixed with 1 μL of an α-cyano-4-hydroxycinnamic 
acid (ACH) matrix then seeded on the MALDI plate and air-
dried. The matrix was prepared from a 10 mg/mL solution of 
ACH in MeCN/H2O 1:1 (v/v) containing 0.1 % TFA. 
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 CD spectra were recorded with a Jasco 810 UV-Vis 
spectropolarimeter, using a Peltier CDF 426S/426L. The spectra 
were obtained in a wavelength range of 190 to 260 nm at a 
spectral bandwidth of 1 nm, with a time response of 4 s, a scan 
speed of 20 nm/min, and a step resolution of 0.1 nm. Each 
spectrum was the average of four accumulations. The spectra 
were measured by dissolving the cyclopeptide in 10 mM 
phosphate buffer at pH 7.4 and were recorded at 25ºC.49 The 
blank was subtracted from each peptide spectrum.  
 1H and 13C NMR spectra of c(KSTAIPF) were recorded on a 
Bruker 600-MHz NMR spectrometer. The samples were 
approximately 3 mM in DMSO-d6. Chemical shifts were 
reported in δ (ppm) relative to the undeuterated fraction of 
DMSO-d6 and to TMS. Amino acid analysis was performed on a 
Beckman system Gold 6300. 
 
4.4. Molecular dynamics simulations 
All systems were initially solvated with TIP3P50 waters in an 
octahedral box spanning 12 Å from the peptide to the edge of 
the box and neutralized with chloride anions or Na+ cations. 
The Amber ff99SB-ILDN51 force field was used as implemented 
in the AMBER12 package.52 The standard protonation state at 
a physiological pH of 7.4 was assigned to the ionizable 
residues. Four minimizations (initially with 2000 cycles of 
steepest descent followed by a maximum of 10000 cycles of 
conjugate gradient) were run sequentially for hydrogen atoms, 
ions, water molecules and finally all atoms. Thermalization and 
first initial MD simulations were run under the canonical 
isochoric-isothermic (NVT) ensemble, and then the canonical 
isothermic-isobaric (NPT) ensemble was used for the rest of 
the MD simulations. Langevin dynamics was employed to 
control the temperature, whereas Berendsen bath coupling 
was used for the pressure (1 atm). A time step of 2 ps was 
used, together with SHAKE,53 a non-bonded cut-off of 15.0 Å, 
and the Particle-Mesh-Ewald (PME) method (grid spacing of 1 
Å) for electrostatic interactions. 
 
4.5. Elucidation of cis and trans monomeric c(KSTAIPF) and other 
monomeric species 
The structure of cis and trans c(KSTAIPF) was resolved by 
means of restrained MD simulations. The starting structure of 
cis c(KSTAIPF) was derived from the X-ray structure of 
c(NSLAIPF) and simulated according to the preceding protocol 
for 200 ns. The other cis cyclopeptides were derived in the 
same way as in the case of cis c(KSTAIPF). The trans c(KSTAIPF) 
was generated by rotating the Ile-Pro peptide bond, and the 
rest of the peptide bonds were manually accommodated using 
the facilities implemented in Pymol.54 Then, the NOE 
correlations observed in the NMR spectra for cis and trans 
c(KSTAIPF) were used to derive suitable distance restraints, 
which were imposed on the subsequent all-atom explicit 
solvent MD simulations. Thermalization comprised four steps 
of 200 ps to heat the system from 150 to 300 K under the 
canonical NVT ensemble, followed by an equilibration step of 1 
ns at 300 K under the canonical NPT ensemble, and finally a 20 
ns MD simulation in which the harmonic restraints (force 
constants of 10 kcal mol-1 Å-2) were gradually removed over 
the last 5 ns. To further explore the structural integrity of the 
candidate structure obtained in the preceding step, two 
replicas of the final structure were subjected to four series of 
simulated annealing cycles from 300 K to 500 K and back to 
300 K in 5 ns NPT simulations for each cycle. Then, the two 
resulting structures were subjected to 200 ns of NPT. No 
significant change was detected in the last 50 ns of the 
trajectories and, more importantly, the same backbone 
conformation was achieved in both replicas, see Figure S7. 
Once the trans c(KSTAIPF) was achieved, the other trans 
cyclopeptides were obtained by simply mutating the 
corresponding residue in the final trans c(KSTAIPF) structure 
and submitting this initial structure to 200 ns of plain MD 
simulations. Gratifyingly, the conformational space occupied in 
the unconstrained MD simulations by each cyclopeptide was 
fairly similar (see Figure 6), which confirms the strategy of the 
structural elucidation of the cis and trans isomers for these 
monomeric cyclopeptides, and also indicates the structural 
integrity of the backbone of the cis and trans conformers. 
 
4.6. Relative stability of cis and trans conformers for all 
monomeric cyclopeptides  
The relative stability of the cis and trans conformers for each 
cyclopeptide was calculated by first, extracting the most 
representative conformations of each conformer; second, 
calculating the energy of each conformation at several levels 
of theory (semiempirical/PM6-DH+/COSMO, DFT/M06-2X/6-
31G(d)/SMD, DFT/M06-2X/6-31G(d,p)/SMD, DFT/M06-
2X/def2tvzp/SMD and MP2/6-31G(d)/SMD); and third, 
applying a weighting scheme according to the Boltzmann 
distribution function to derive the relative free energy 
between the two isomers.  
 In more detail, the most diverse conformations were 
selected from the conformational ensemble previously 
generated by 200 ns (2500 frames) of unconstrained MD 
simulations for each conformer of all five cyclopeptides. To 
that end, the k-means clustering technique applied to the 
Cartesian coordinates of non-hydrogen atoms classified the 
initial 2500 frames into 75 clusters. The most populated 
clusters which covered at least 75 % of the conformational 
space were selected and the closest conformations to the 
centre of these clusters selected (256 conformations in total). 
The number of conformations selected for the conformers of 
each cyclopeptide is shown in Table S3. The Gibbs free 
energies in implicit aqueous solutions for all the conformations 
of each cyclopeptide were initially determined by 
semiempirical calculations using the PM6-DH+/COSMO 
method, as implemented in MOPAC2012.55 Then, DFT 
calculations at the M06-2X/6-31G(d) level, as implemented in 
Gaussian09 package, were also performed.56 These 
semiempirical and DFT calculations involved full geometry 
optimizations followed by vibrational frequency calculations 
under the effect of a polarizable continuum model of water 
(dielectric constant: 78.4), using COSMO57 for PM6-DH+ and 
using SMD58 with radii and non-electrostatic terms from 
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Truhlar and coworkers for DFT/M06-2X. Vibrational 
frequencies were computed to verify that the optimized 
cyclopeptides were at the minimum of their potential energy 
surface and no imaginary frequencies were found in any of the 
conformations. The values of the electronic energy were then 
corrected with the zero-point vibrational energy, as well as the 
translational, rotational, and vibrational energies at 298.15 K, 
thus allowing the computation of the Gibbs free energy at the 
same temperature. In the case of the theoretical levels of 
theory corresponding to DFT/M06-2X/6-31G(d,p)/SMD, 
DFT/M06-2X/def2-tvzp/SMD and MP2/6-31G(d)/SMD, only the 
conformations with a population weight  (calculated according 
to the Boltzmann distribution of the energy without thermal 
corrections) higher than 5% (67 conformations, see Table S4) 
at the level of DFT/M06-2X/6-31G(d)/SMD were subjected to 
geometry optimization (the former) or just single point 
calculations (the latter two). Finally, the relative free energies 
and relative energies (depending on the theoretical level of 
theory) of the cis and trans isomers of all cyclopeptide were 
derived from their Boltzmann distributions. 
 
4.7. Elucidation of the dimeric form of trans c(KSTAIPF) and the 
other dimers 
A systematic exploration of the relative orientation of two 
copies of trans c(KSTAIPF) was undertaken taking into account 
that only one of the monomer surfaces appears to be well 
suited to effective aggregation. This is because the side chains 
are oriented towards one face of the cyclopeptide, whereas 
the other face contains peptide bonds that can readily interact 
in hydrogen bonds. The computational protocol is shown in 
Figure S9. Briefly, the orientations were built under the 
premise of maximizing the number of intermonomeric 
hydrogen bonds and reducing the repulsive electrostatic 
interaction between the Lys residues in the interacting 
monomers. This process led to five distinct relative 
orientations that can be named according to the residues in 
the two peptides that are placed facing each other in the initial 
structure. The structural integrity of the five cases was 
examined via MD simulations. To this end, suitable restraints 
on the intermolecular hydrogen bonds were introduced in 
order to avoid artefactual rearrangements during equilibration 
and in a subsequent 20 ns trajectory, the restraints being 
gradually removed over the last 5 ns. The systems were then 
simulated for 100 ns with the only restriction of keeping the 
centre of mass of the C alpha carbon atoms of both monomers 
at a distance of less than 10 Å in order to allow the structural 
relocations of the monomers in the dimer. Analysis of the 
trajectories revealed a preferential orientation characterized 
by the intermonomeric backbone hydrogen bond between Ala 
and Ser, and the apolar interaction between Pro residues. 
Finally, to further explore the integrity of the dimeric species, a 
series of eight replicas were simulated for 100 ns. In five cases, 
the dimer retained the original structure, and in two cases the 
final structure showed a slight rearrangement to a similar 
orientation. Only in one replica was the dimer broken, leading 
to separated monomers at the end of the simulation. Finally, 
one of the succeeded replicas was extended up to 200 ns and 
used for the analysis. 
 
4.8 MM-GBSA, MM-PBSA and MM-RISM methods for estimation 
of the binding energy 
The energetics of dimerization was determined using the MM-
GBSA (molecular mechanics/generalized Born surface area), 
MM-PBSA (molecular mechanics/Poisson Boltzmann surface 
area) and MM-RISM (molecular mechanics/reference 
interaction site model)59 methods, as implemented in the 
python version60 of AMBER12 for 500 uniformly spaced 
snapshots taken from the last 100 ns of each dimer simulation. 
The MM-GB(PB)SA binding free energy accounts for the 
electrostatic, van der Waals, polar solvation and apolar 
solvation terms, and is calculated with an ionic strength of 
0.150 M, and internal and external dielectric constants of the 
solute and solvent of 2 and 80, respectively. Meanwhile, MM-
RISM is an attractive and a higher-level alternative to 
continuum solvation models such as MM-GB(PB)SA. It is based 
on solvent distributions rather than individual molecules, and 
yields the solvation structure and thermodynamics from first 
principles of statistical mechanics. The conformational 
entropic contribution is not included since it can be assumed 
to have minimal impact on the relative difference in the 
binding energy between the two systems, due to the isomeric 
form of the dimers. The R program61 was used for all statistical 
analysis and Pymol for molecular graphics. 
 
c(Asn-Ser-Leu-Ala-Ile-Pro-Phe), c(NSLAIPF), Stylostatin 1 (33 
mg, 13 % yield, 92 % HPLC purity). HPLC: tr = 10.43 min (0 → 
100% gradient in 15 min); HPLC: tr = 10.24 min (15 → 70 % 
gradient in 15 min); HPLC: tr = 11.61 min (25 → 35 % gradient 
in 15 min). MALDI-TOF: [M+H]+ 743.45, [M+Na]+ 765.43, 
[M+K]+ 781.41, [2M+H]+ 1485.63. AAA: Asn 1.00; Ser 0.79; Leu 
0.83; Ala 1.05; Ile 1.00; Pro 1.10; Phe 1.01. 
 
c(Asn-Ser-Thr-Ala-Ile-Pro-Phe), c(NSTAIPF), (30 mg, 15% yield, 
93% HPLC purity). HPLC: tr = 9.57min (0 → 100% gradient in 15 
min); HPLC: tr = 8.73min (15 → 70% gradient in 15 min). 
MALDI-TOF: [M+Na]+ 753.39, [M+K]+ 769.37. AAA: Asn 1.00; 
Ser 0.7; Thr 0.8; Ala 1.00; Ile 1.00; Pro 1.00; Phe 1.00.  
 
c(Lys-Ser-Thr-Ala-Ile-Pro-Phe), c(KSTAIPF), (15 mg, 5% yield, 
95% HPLC purity).  HPLC: tr = 8.5 and 8.7 min, 0 → 100% 
gradient in 15 min); HPLC: tr = 8.25 min (15 → 45 % gradient in 
15 min, T = 45 ºC). MALDI-TOF: [M+H]+ 745.46, [M+Na]+ 
767.44, [2M+H]+ 1489.89. AAA: Lys 1.01; Ser 0.82; Thr 0.90; Ala 
1.02; Ile 0.97; Pro 1.08; Phe 1.02. 1H-NMR trans (600 MHz, 
DMSO-d6, δ in ppm): Lysine: 18.03 (NH), 4.47  (Hα), 1.51 (Hβ), 
1.29 and 1.36  (Hγ), 1.47 and 1.56 (Hδ), 2.73  (Hε), 7.67  (NH2); 
Serine: 8.67 (NH), 4.56 (Hα), 4.19 and 3.67 (Hβ); Threonine: 
8.16 (NH), 3.68 (Hα), 3.98 (Hβ), 1.15 (Hγ); Alanine: 7.60 (NH), 
4.31 (Hα),  1.22 (Hβ); Isoleucine: 6.95 (NH), 4.49 (Hα),  1.74 
(Hβ), 1.36 and 0.98 (Hγ), 0.85  (Cγ-CH3), 0.76  (Cδ-CH3); Proline: 
3.96 (Hα), 1.72 and 1.81 (Hβ), 1.89 and 1.98 (Hγ), 3.57 and 
3.74 (Hδ); Phenylalanine: 8.57 (NH), 3.71 (Hα), 3.46 and 3.22 
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(Hβ). 13C-NMR trans (150 MHz, DMSO-d6, δ in ppm): Lysine:  
53.9 (Cα), 26.0 (Cβ), 21.8  (Cγ), 32.8  (Cδ), 38.4  (Cε);  Serine: 
53.5 (Cα), 62.1 (Cβ); Threonine: 61.9 (Cα), 64.8 (Cβ), 20.4 (Cγ); 
Alanine: 48.1 (Cα), 18.7 (Cβ); Isoleucine: 52.9 (Cα), 36.7 (Cβ), 
23.6 (Cγ), 13.9  (Cγ-CH3), 9.9  (Cδ-CH3); Proline: 60.6 (Cα), 28.7 
(Cβ), 24.1 (Cγ), 47.6 (Cδ); Phenylalanine: 57.5 (Cα), 33.7 (Cβ). 
1H-NMR cis (600 MHz, DMSO-d6, δ in ppm): Lysine: 7.64 (NH), 
4.51 (Hα), 1.51 (Hβ), 1.23 (Hγ), 1.70 and 1.95 (Hδ), 2.68 (HCε), 
7.59 (NH2); Serine: 9.03 (NH), 3.87 (Hα), 3.71 (Hβ); Threonine: 
6.65 (NH); 3.99 (Hα); 1.04 (Hβ); Alanine: 7.26 (NH), 4.42 (Hα), 
1.14 (Hβ); Isoleucine: 8.73 (NH), 3.97 (Hα), 1.73 (Hβ) , 0.81  
(Cγ-CH3 and Cδ-CH3); Proline: 4.35 (Hα), 1.67  and 1.99 (Hβ),  
0.71 and 1.49 (Hγ), 2.80 and 3.23 (Hδ); Phenylalanine: 8.29 
(NH), 4.23 (Hα), 3.21 and 3.02 (Hβ). 13C-NMR cis (150 MHz, 
DMSO-d6, δ in ppm) Lysine: 50.9 (Cα), 23.8 (Cβ), 21.2  (Cγ), 
32.1  (Cδ), 38.5 (Cε); Serine: 58.9 (Cα), 59.6 (Cβ); Threonine: 
57.5 (Cα), 20.3 (Cβ); Alanine: 47.9 (Cα), 16.0 (Cβ); Isoleucine: 
60.5 (Cα), 34.9 (Cβ), 14.3 (Cγ-CH3 and Cδ-CH3); Proline: 59.8 
(Cα), 30.1 (Cβ), 20.4 (Cγ), 45.4 (Cδ); Phenylalanine: 56.6 (Cα), 
36.9 (Cβ). 
 
c(Arg-Ser-Thr-Ala-Ile-Pro-Phe), c(RSTAIPF), (16.1 mg, 12% 
yield, 88% HPLC purity). HPLC: tr = 8.72 min (0 → 100% 
gradient in 15 min); HPLC: tr = 8.63 min (0 → 100% gradient in 
15 min, T = 45 ºC);  HPLC: tr = 7,47 min, gradient 15 → 70% in 
15 min, T = 45 ºC). MALDI-TOF: [M+H]+ 773.46, [2M+H]+ 
1545.89. AAA: Arg 1.06; Ser 0.81; Thr 0.93; Ala 1.01; Ile 0.94; 
Pro 1.04; Phe 1.02. 
 
c(Asp-Ser-Thr-Ala-Ile-Pro-Phe), c(DSTAIPF), (12 mg, 12% yield, 
85% HPLC purity).  HPLC: tr = 9.78 min (0 → 100% gradient in 
15 min); HPLC: tr = 11.69 min (15 → 40 % gradient in 15 min). 
MALDI-TOF: [M+H]+ 732.45, [M+Na]+ 754.43, [M+K]+ 770.41. 
AAA: Lys 1.02; Ser 0.76; Thr 0.90; Ala 1.05; Ile 0.91; Pro 1.06; 
Phe 1.06. 
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